{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:47:53Z","timestamp":1788353273401,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA210509"],"award-info":[{"award-number":["R01 CA210509"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180821"],"award-info":[{"award-number":["U10CA180821"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180882"],"award-info":[{"award-number":["U10CA180882"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA196171"],"award-info":[{"award-number":["U24CA196171"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA232760"],"award-info":[{"award-number":["UG1CA232760"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.annonc.2022.07.1942","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T17:52:07Z","timestamp":1660153927000},"page":"1159-1167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]"],"prefix":"10.1016","volume":"33","author":[{"given":"B.","family":"Saberzadeh-Ardestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.","family":"Smyrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Sinicrope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.annonc.2022.07.1942_bib1","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.annonc.2022.07.1942_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.annonc.2020.01.011","article-title":"Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)","volume":"31","author":"Lee","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2022.07.1942_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/1078-0432.CCR-18-1984","article-title":"Intertumoral heterogeneity of CD3(+) and CD8(+) T-cell densities in the microenvironment of DNA mismatch-repair-deficient colon cancers: implications for prognosis","volume":"25","author":"Yoon","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"5795","key":"10.1016\/j.annonc.2022.07.1942_bib4","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"10135","key":"10.1016\/j.annonc.2022.07.1942_bib5","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.annonc.2022.07.1942_bib6","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1158\/1078-0432.CCR-09-1438","article-title":"Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype","volume":"15","author":"Ogino","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.annonc.2022.07.1942_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3393\/ac.2018.12.17","article-title":"Differences regarding the molecular features and gut microbiota between right and left colon cancer","volume":"34","author":"Kim","year":"2018","journal-title":"Ann Coloproctol"},{"issue":"7","key":"10.1016\/j.annonc.2022.07.1942_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ng1834","article-title":"CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer","volume":"38","author":"Weisenberger","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.annonc.2022.07.1942_bib9","article-title":"Prognostic immune-related analysis based on differentially expressed genes in left- and right-sided colon adenocarcinoma","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.annonc.2022.07.1942_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/bjc.2017.448","article-title":"Tumour sidedness and intrinsic subtypes in patients with stage II\/III colon cancer: analysis of NSABP C-07 (NRG Oncology)","volume":"118","author":"Kim","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annonc.2022.07.1942_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.592351","article-title":"Impact of tumor side on clinical outcomes in stage II and III colon cancer with known microsatellite instability status","volume":"11","author":"Akce","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2022.07.1942_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","article-title":"Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis","volume":"3","author":"Petrelli","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.annonc.2022.07.1942_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2017","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.annonc.2022.07.1942_bib14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.annonc.2022.07.1942_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2012.385","article-title":"Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial","volume":"307","author":"Alberts","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.annonc.2022.07.1942_bib16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"282","key":"10.1016\/j.annonc.2022.07.1942_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.annonc.2022.07.1942_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc Series B (Methodol)"},{"issue":"1","key":"10.1016\/j.annonc.2022.07.1942_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2014.09.041","article-title":"Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes","volume":"148","author":"Sinicrope","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.annonc.2022.07.1942_bib20","doi-asserted-by":"crossref","first-page":"djw272","DOI":"10.1093\/jnci\/djw272","article-title":"Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer","volume":"109","author":"Taieb","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.annonc.2022.07.1942_bib21","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.08.056","article-title":"Roles for Interleukin 17 and adaptive immunity in pathogenesis of colorectal cancer","volume":"155","author":"Hurtado","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.annonc.2022.07.1942_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annonc.2022.07.1942_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.498502","article-title":"Microbial community profiling distinguishes left-sided and right-sided colon cancer","volume":"10","author":"Zhong","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.annonc.2022.07.1942_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.annonc.2022.07.1942_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa023","article-title":"Contribution of Immunoscore and molecular features to survival prediction in stage III colon cancer","volume":"4","author":"Sinicrope","year":"2020","journal-title":"JNCI Cancer Spectr"},{"issue":"7","key":"10.1016\/j.annonc.2022.07.1942_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3695","article-title":"Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status","volume":"4","author":"Taieb","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.annonc.2022.07.1942_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3389\/fimmu.2018.01578","article-title":"Immune landscape of colorectal cancer tumor microenvironment from different primary tumor location","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.annonc.2022.07.1942_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.annonc.2022.07.1942_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.annonc.2022.07.1942_bib30","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/s41467-020-19288-6","article-title":"Immune modulatory effects of oncogenic KRAS in cancer","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.annonc.2022.07.1942_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073616","article-title":"Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-\u03b3","volume":"8","author":"Petanidis","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.annonc.2022.07.1942_bib32","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-12-1632","article-title":"Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma","volume":"18","author":"Khalili","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.annonc.2022.07.1942_bib33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41416-019-0559-6","article-title":"Intratumoural-infiltrating CD4\u00a0+ and FOXP3\u00a0+ T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer","volume":"121","author":"Kuwahara","year":"2019","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.annonc.2022.07.1942_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042274","article-title":"Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas","volume":"7","author":"Yoon","year":"2012","journal-title":"PLoS One"},{"issue":"164","key":"10.1016\/j.annonc.2022.07.1942_bib35","doi-asserted-by":"crossref","first-page":"164ra159","DOI":"10.1126\/scitranslmed.3004566","article-title":"Expression of ROR\u03b3t marks a pathogenic regulatory T cell subset in human colon cancer","volume":"4","author":"Blatner","year":"2012","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.annonc.2022.07.1942_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.53","article-title":"Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location","volume":"7","author":"Mima","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.annonc.2022.07.1942_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jamaoncol.2015.1377","article-title":"Fusobacterium nucleatum and T cells in colorectal carcinoma","volume":"1","author":"Mima","year":"2015","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2022.07.1942_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3748\/wjg.v22.i2.557","article-title":"Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer","volume":"22","author":"Nosho","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.annonc.2022.07.1942_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/gutjnl-2015-309595","article-title":"Tumour-associated and non-tumour-associated microbiota in colorectal cancer","volume":"66","author":"Flemer","year":"2017","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.annonc.2022.07.1942_bib40","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2016-313498","article-title":"Gut microbiota modulate T cell trafficking into human colorectal cancer","volume":"67","author":"Cremonesi","year":"2018","journal-title":"Gut"},{"issue":"39","key":"10.1016\/j.annonc.2022.07.1942_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017221","article-title":"Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.annonc.2022.07.1942_bib42","article-title":"Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753422037942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753422037942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:15:01Z","timestamp":1760336101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753422037942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0923753422037942"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2022.07.1942","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2022.07.1942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Medical Oncology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}